Root Coverage With Tunneling Technique With Connective Tissue Versus Coronal Advancement Flap Tec… (NCT06228534) | Clinical Trial Compass
CompletedEarly Phase 1
Root Coverage With Tunneling Technique With Connective Tissue Versus Coronal Advancement Flap Technique.
Ecuador20 participantsStarted 2024-01-15
Plain-language summary
This is a randomized triple-blind clinical trial. This comparative clinical study investigates the efficacy of root coverage using two periodontal techniques: the tunneling technique and the coronal advancement technique. The objective is to evaluate and compare the clinical, esthetic and patient perception outcomes after undergoing each procedure. Participants with specific gingival recessions will be included, and follow-up will be performed to measure root coverage, keratinized tissue gain and other relevant parameters. In addition, a detailed analysis of the morbidity associated with each technique will be performed. This study aims to provide valuable information to guide oral health professionals in choosing the most appropriate technique for the treatment of gingival recessions.
Who can participate
Age range
20 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Non-smoking
* No systemic diseases, no pregnancy
* No active periodontal disease
* Bacterial plaque and bleeding Score ≤9%.
* No medication that interferes with periodontal tissue health or scarring.
* Teeth without root canal treatments
* No contraindication to periodontal surgery
* Presence of at least one type I and II Miller O RT1 - RT2 recession defect with at least 4 recessions in the upper or lower jaw that clearly shows the amelocementary limit.
* Work will be done on upper central incisors, upper lateral incisors, upper canines and upper premolars.
* For the coronal advancement technique, multiple or unitary gingival recessions will be used
Exclusion Criteria:
* SMOKING PATIENT
* PATIENT WITH A SYSTEMIC DISEASE
* WITH PERIODONTAL DISEASE
* GINGIVAL RECESSION CLASS III OR RT3
* PATIENT WITH EDENTULISM
* PATIENT WITHOUT AMELOCEMENTARY LIMIT
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.